European guidelines propose a 0.5 mg/kg/day dose of oral prednisone as initial treatment of bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent, and patients'general condition.
International multicentre observational study to assess the efficacy and safety of a 0.5 mg/kg/day starting dose of oral corticosteroids to treat bullous pemphigoid / Hébert, V; Bastos, S; Drenovska, K; Meijer, J; Ingen-Housz-Oro, S; Bedane, C; Lunardon, L; Debarbieux, S; Jedlickova, H; Cauxv, F; Chaby, G; D'Incan, M; Feliciani, C; Boulard, C; Schumacher, N; Schmidt, E; Roussel, A; Richard, M A; Gottlieb, J; Ferranti, V; Guérin, O; Bénichou, J; Joly, P. - In: BRITISH JOURNAL OF DERMATOLOGY. - ISSN 0007-0963. - (2021). [10.1111/bjd.20593]
International multicentre observational study to assess the efficacy and safety of a 0.5 mg/kg/day starting dose of oral corticosteroids to treat bullous pemphigoid
Feliciani, CMembro del Collaboration Group
;
2021-01-01
Abstract
European guidelines propose a 0.5 mg/kg/day dose of oral prednisone as initial treatment of bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent, and patients'general condition.| File | Dimensione | Formato | |
|---|---|---|---|
|
Br J Dermatol - 2021 - H bert - International multicentre observational study to assess the efficacy and safety of a 0 5 mg.pdf
non disponibili
Tipologia:
Versione (PDF) editoriale
Licenza:
Creative commons
Dimensione
1.21 MB
Formato
Adobe PDF
|
1.21 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
